[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"hysteroscopic-myomectomy\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:hysteroscopic-myomectomy":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":29,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":5},"100519914","phase-4-use-of-misoprostol-in-hysteroscopic-myomectomy-100519914",false,"NCT06049745","Use of Misoprostol in Hysteroscopic Myomectomy","Use of Misoprostol in Hysteroscopic Myomectomy, a Randomized Peospective Trial","Inclusion Criteria:\n\n* women between the ags of 20 years- 55 years, inclusive\n* undergoing hysteroscopic myomectomy\n* submucosal fibroid less than 40 mm (type 0, 1 and 2)\n* up to 2 submucosal fibroids\n* patients are able to provide written informed consent\n\nExclusion Criteria:\n\n* post menopausal women\n* inability to perform operative hysteroscopy under anesthesia in the past due to cervical stenosis\n* previous PID or documented tubal occlusion\n* positive BHCG test\n* inability to consent due to cognitive or language barrier\n* allergy to misoprostole\n* severe COPD, asthma or cardiac disease",true,"FEMALE","20 Years","55 Years",{"count":21,"type":22},200,"ESTIMATED","INTERVENTIONAL",[25],"PHASE4","Hysteroscopic myomectomy is typically suitable for myomas measuring under 4 cm in size. The utilization of misoprostol before the procedure can facilitate uterine access, decrease fluid absorption, and reduce blood loss, consequently leading to a decrease in the overall procedure time. In this randomized trial, the investigators aim to investigate the impact of misoprostol administration and its effects on each of the mentioned parameters.",[28],"Hysteroscopic Myomectomy",[30,31],"hysteroscopic myomectomy","misoprostol","NOT_YET_RECRUITING","2023-09-16",{"date":35,"type":36},"2023-09-22","ACTUAL",{"date":38,"type":22},"2023-11",{"date":40,"type":22},"2026-10",{"name":42,"class":43},"Assuta Ashdod Hospital","OTHER"]